Private equity firm 21 Invest France has acquired ProductLife Group, a business which provides outsourced management and regulatory services for pharmaceutical laboratories.
The group was established in 1994 and now has more than 300 clients, with total sales of €25 million (£21.9 million).
With the support of 21 Invest France, ProductLife Group plans to expand further overseas and launch new services in related markets such as medical equipment.
Pierre Cuny, Executive Chair of ProductLife Group, said: “We are happy to count on the support of a new reference shareholder as prestigious as 21 Invest. We trust it will actively support the group's ambitious development plan to serve its customers.”
Fabrice Voituron, Partner at 21 Invest France, added: “ProductLife is ideally positioned in a booming market. We are delighted to accompany the team in the realization of its project combining resilience, strong growth and acquisition opportunities allowing ProductLife to reveal its full potential and become an undisputed leader on its market.”